Passer au contenu

PARLINFO

 

L'hon. Lillian Eva Dyck

Sénatrice actuelle - Saskatchewan

Lieu de naissance :  North Battleford, Saskatchewan, Canada

Profession | Occupation :  activiste, professeure, doyenne associée, scientifique, recherchiste, neurochimiste

Notes : Membre de la première nation de Gordon. Crie

Coordonnées

Préférence linguistique :  Anglais

Adresse parlementaire

Sénat du Canada
Ottawa, Ontario
K1A 0A4
  Sans frais : 1-800-267-7362
  Téléphone: 613-995-4318
  Télécopieur: 613-995-4331
  Courriel : lillian.dyck@sen.parl.gc.ca

Expérience politique fédérale

Années de service : 5 048 jours (13 années, 9 mois, 26 jours)

Sénat

Division sénatoriale Affiliation politique à la nomination Mandat Nommé sur avis de
Saskatchewan Nouveau Parti démocratique 2005-03-24 -   Paul Edgar Philippe Martin

Groupe parlementaire

Parti Mandat
Parti libéral du Canada 2009-01-15 -  
Nouveau Parti démocratique 2005-03-24 - 2006-10-30
Indépendant (Nouveau Parti démocratique) 2006-10-31 - 2009-01-14
Comités - Sénat

On trouve ci-après la composition des comités par session. Tous les parlementaires ayant siégé à un comité à tout moment durant une session figurent sur la liste.

Comité Rôle Mandat
Comité permanent des affaires juridiques et constitutionnelles Membre 42e législature, 1re session
(2015-12-03 -  )
Comité permanent des peuples autochtones Présidente 42e législature, 1re session
(2015-12-10 -  )
Comité permanent des peuples autochtones Vice-présidente 40e législature, 3e session
(2010-03-04 - 2011-03-26)
Comité permanent des peuples autochtones Vice-présidente 41e législature, 2e session
(2013-11-19 - 2015-08-02)
Comité permanent des peuples autochtones Vice-présidente 41e législature, 1re session
(2011-06-14 - 2013-09-13)
Comité permanent des peuples autochtones Membre 42e législature, 1re session
(2015-12-09 -  )
Comité permanent des peuples autochtones Membre 39e législature, 2e session
(2007-11-01 - 2008-09-07)
Comité permanent des peuples autochtones Membre 40e législature, 2e session
(2009-02-10 - 2009-12-30)
Comité permanent des affaires sociales, des sciences et de la technologie Membre 40e législature, 2e session
(2009-02-10 - 2009-12-30)
Sous-comité sur les villes du Comité sénatorial permanent des affaires sociales, des sciences et de la technologie Membre 40e législature, 2e session
(2009-02-25 - 2009-12-30)
Comité permanent de l’énergie, de l’environnement et des ressources naturelles Membre 40e législature, 3e session
(2010-04-12 - 2010-04-14)
Comité permanent des affaires sociales, des sciences et de la technologie Membre 40e législature, 3e session
(2010-03-04 - 2011-03-26)
Comité permanent des droits de la personne Membre 40e législature, 3e session
(2010-05-13 - 2010-08-25)
Comité permanent de l’énergie, de l’environnement et des ressources naturelles Membre 41e législature, 1re session
(2012-06-05 - 2012-06-05)
Comité permanent des affaires sociales, des sciences et de la technologie Membre 41e législature, 1re session
(2013-03-18 - 2013-05-01)
Comité permanent des droits de la personne Membre 41e législature, 1re session
(2011-11-21 - 2011-11-22)
Comité permanent des peuples autochtones Membre 41e législature, 2e session
(2013-10-24 - 2015-08-02)
Comité permanent des affaires sociales, des sciences et de la technologie Membre 41e législature, 2e session
(2013-10-24 - 2014-03-26)
Comité permanent des peuples autochtones Membre 39e législature, 1re session
(2006-04-06 - 2007-09-14)
Comité permanent des affaires sociales, des sciences et de la technologie Membre 42e législature, 1re session
(2015-12-09 -  )
Comité permanent des pêches et des océans Membre 42e législature, 1re session
(2015-12-03 -  )
Comité permanent des peuples autochtones Membre 41e législature, 1re session
(2011-06-09 - 2013-09-13)

Publications choisies

Le document suivant est une bibliographie sélective contenant les principaux titres ou contributions de la collection d’ouvrages publiés par des parlementaires. Pour en apprendre davantage au sujet des œuvres écrites par des parlementaires, consultez une bibliothèque près de chez vous.

Aucun effort n’a été ménagé pour garantir l’exactitude de l’information qui suit. Si vous trouvez des erreurs, écrivez-nous à parlinfo@parl.gc.ca.

Potentiation of the biochemical effects of beta-phenylethylhydrazine by deuterium substitution. Biochemical Pharmacology. 32 (9):1519-22 May 1, 1983

Release of monoamines from striatal slices by phenelzine and beta-phenylethylamine. Progress in Neuro-psychopharmacology & Biological Psychiatry. 7 (4):797-800 1983

Inhibition of polyphosphoinositide turnover in rat cerebral cortex by clonidine. Life Sciences. 45 (11):993-9 1989

Polymorphism of a class 3 aldehyde dehydrogenase present in human saliva and in hair roots. Alcoholism, Clinical and Experimental Research. 19 (2):420-6 Apr. 1995

Effect of deuterium substitution on the disposition of intraperitoneal tryptamine. Biochemical Pharmacology. 35 (17):2893-6 Sept. 1, 1986

Cutaneous vasomotor sensitivity to ethanol and acetaldehyde: subtypes of alcohol-flushing response among Chinese. Alcoholism, Clinical and Experimental Research. 14 (6):932-6 Dec. 1990

Methylphenidate-like stimulants in vitro release [3H]tyramines but not [14C]dopamine. European Journal of Pharmacology. 69 (3):371-4 Jan. 29, 1981

Uptake of para-tyramine and meta-tyramine into slices of the caudate nucleus and hypothalamus of the rat. Neurochemical Research. 4 (5):633-42 Oct. 1979

Effect of chronic deuterated and non-deuterated phenelzine on rat brain monoamines and monoamine oxidase. Naunyn-Schmiedeberg's Archives of Pharmacology. 337 (3):279-83 Mar. 1988

Tryptamine transport in rat brain slices: a comparison with 5-hydroxytryptamine. Neurochemical Research. 9 (95):617-28 May 1984

Effects of beta-phenylethylamine on polyphosphoinositide turnover in rat cerebral cortex. Neurochemical Research. 14 (1):63-7 Jan. 1989

The biosynthesis of p-tyramine, m-tyramine, and beta-phenylethylamine by rat striatal slices. Journal of Neuroscience Research. 10 (2):211-20 1983

Effect of monofluoromethyldopa (MFMD) on trace amine levels. Life Sciences. 40 (6):571-5 Feb. 9, 1987

Isoenzymes of aldehyde dehydrogenase in human lymphocytes. Alcoholism, Clinical and Experimental Research. 14 (4):534-8 Aug. 1990

The role of catecholamines, 5-hydroxytryptamine and m-tyramine in the behavioural effects of m-tyrosine in the rat. European Journal of Pharmacology. 84 (3):139-49 Oct. 22, 1982

Conjugation of phenylacetic acid and m- and p-hydroxyphenylacetic acids in the rat striatum. Life Sciences. 53 (11):901-9 1993

Inibition of rat liver microsomal CYP1A2 and CYP2B1 activity by N-(2-heptyl)-N-methyl-propargylamine and by N-(2-heptyl)-propargylamine. Drug Metabolism and Disposition. 29 (8):1156-61 Aug. 2001

Effects of monoamine oxidase inhibitors on the acid metabolites of some trace amines and of dopamine in the rat striatum. Biochemical Pharmacology. 45:1317-22 Mar. 24, 1993

Biphasic behavioural stimulation induced by a monoamine oxidase-inhibiting antidepressant. Progress in Neuro-psychopharmacology & Biological Psychiatry. 6 (4):383-8 1982

Inhibition of aromatic L-amino acid decarboxylase and tyrosine aminotransferase by the monoamine oxidase inhibitor phenelzine. Journal of Neurochemistry. 46 (6):1899-903 June 1986

Release of some endogenous trace amines from rat striatal slices in the presence and absence of a monoamine oxidase inhibitor. Life Sciences. 44 (17):1149-56 1989

The in vitro release of endogenous m-tyramine, p-tyramine and dopamine from rat striatum. Neurochemical Research. 7 (6):705-16 June 1982

Absence of the atypical mitochondrial aldehyde dehydrogenase (ALDH2) isozyme in Saskatchewan Cree Indians. Human Heredity. 43 (2):116-20 Mar./Apr. 1993

Behavioural and neurochemical effects of meta-tyrosine in the rat. Progress in Neuro-psychopharmacology & Biological Psychiatry. 6 (4):389-94 1982

Involvement of brain trace amines in the behavioural effects of phenelzine. Neurochemical Research. 13 (2):113-9 Feb. 1988

Acceleration of the biosynthesis of rat striatal dopamine by incubation and by administration of gamma-butyrolactone. Journal of Neuroscience Research. 8 (1):57-65 1982

Atypical antipsychotics attenuate neurotoxicity of beta-amyloid(25-35) by modulating Bax and Bcl-X(l/s) _expression and localization. Journal of Neuroscience Research. 74 (6):942-7 Dec .15, 2003

Metabolism and pharmacokinetics, in the rat, of (R)-N-(2-Heptyl)Methyl-propargylamine (R-2HMP), a new potent monoamine oxidase inhibitor and antiapoptotic agent. Drug Metabolism and Disposition. 28 (2):147-54 Feb. 2000

Uptake and release of meta-tyramine, para-tyramine, and dopamine in rat striatal slices. Neurochemical Research. 3 (6):775-91 Dec. 1978

Dare to be brave: stand up for yourself. In : Women in the Canadian academic tundra: challenging the chill / [edited by] Elena Hannah, Linda Paul, Swani Vethamany-Globus. Montreal: McGill-Queen's University Press; p. 47-50. c2002

A comparison of the effects of methylphenidate and amphetamine on the simultaneous release of radiolabelled dopamine and p- or m-tyramine from rat striatal slices. European Journal of Pharmacology. 68 (1):33-40 Nov. 7, 1980

Olanzapine and quetiapine protect PC12 cells from beta-amyloid peptide(25-35)-induced oxidative stress and the ensuing apoptosis. Journal of Neuroscience Research. 81 (4):572-80. Aug. 15, 2005

Alterations in trace amine and trace acid concentrations in isolated aggressive mice. Pharmacology, Biochemistry, and Behavior. 17 (6):1291-4 Dec. 1982

Formation of beta-phenylethylamine from the antidepressant, beta-phenylethylhydrazine. Biochemical Pharmacology. 34 (1):1925-9 June 1, 1985

Effects of deuterium substitution on the catabolism of beta-phenylethylamine: an in vivo study. Journal of Neurochemistry. 46 (2):399-404 Feb. 1986

The University of Saskatchewan: a portrait. Women's Education. 9 (2):23 1991

Antipsychotic drugs cause glial cell line-derived neurotrophic factor secretion from C6 glioma cells. Journal of Psychiatry and Neuroscience. 31 (1):32-7 Jan. 2006

Biosynthesis and excretion of meta and para tyramine in the rat. Life Sciences. 14 (12):2497-506 June 16, 1974

Potentiation of the behavioural effects of the antidepressant phenelzine by deuterium substitution. Psychopharmacology. 81 (2):122-5 1983

Reversible amine -- selective effects of acute and chronic brofaromine treatment in the rat. Life Sciences. 51 (1):59-66 1992

Microassay for the estimation of monoamine oxidase activity. Analytical Biochemistry. 72:637-42 May 7, 1976

The behavioural effects of phenelzine and phenylethylamine may be due to amine release. Brain Research Bulletin. 12 (1):23-8 Jan. 1984

Demonstration of an anti-oxidative stress mechanism of quetiapine. FEBS Journal. 275 (14):3718-28 Jul. 2008

An in vitro study of the uptake and release of m- and p-tyramine. Thesis (Ph.D.) -- University of Saskatchewan; xiii, 157 leaves. 1981

Effect of decarboxylase inhibitors on brain p-tyrosine levels. Biochemical Pharmacology. 36 (8):1373-6 Apr. 15, 1987

Changes in brain catecholamine levels following DL-dopa are not potentiated by deuterium substitution. Progress in Neuro-psychopharmacology & Biological Psychiatry. 9 (5):675-80 1985

Hydroxylation of beta-phenylethylamine in the rat. Life Sciences. 15 (9):1673-83 Nov. 1, 1974

Release of radiolabeled dopamine, p-tyramine, and m-tyramine from rat striatal slices by some aminotetralins. Neurochemical Research. 6 (4):365-75 Apr. 1981

Effects of antidepressant drugs on inositol phospholipid hydrolysis in rat cerebral cortical slices. Neurochemical Research. 14 (11):1047-52 Nov. 1989

The effect of some drugs on the urinary excretion of some aryl alkyl amines in the rat. Research Communications in Chemical Pathology and Pharmacology. 11 (1):73-7 May 1975

Identification and metabolism of certain biogenic amines in brain: a thesis submitted to the Faculty of Graduate Studies in partial fulfilment of the requirements for the degree of Master of Science in the Department of Biochemistry. Saskatoon, Sask.: s.n.; x, 95 leaves. 1970

Effect of deuterium substitution on the penetration of beta-phenylethylhydrazine into the rat brain. Biochemical Pharmacology. 37 (13):2703-4 July 1, 1988

Aliphatic N-methylpropargylamines: monoamine oxidase-B inhibitors and antiapoptotic drugs. Advances in Pharmacology. 42:308-11 1998

Coordonnées

Préférence linguistique :  Anglais

Adresse parlementaire

Sénat du Canada
Ottawa, Ontario
K1A 0A4
  Sans frais : 1-800-267-7362
  Téléphone: 613-995-4318
  Télécopieur: 613-995-4331
  Courriel : lillian.dyck@sen.parl.gc.ca

Expérience politique fédérale

Années de service : 5 048 jours (13 années, 9 mois, 26 jours)

Sénat

Division sénatoriale Affiliation politique à la nomination Mandat Nommé sur avis de
Saskatchewan Nouveau Parti démocratique 2005-03-24 -   Paul Edgar Philippe Martin

Groupe parlementaire

Parti Mandat
Parti libéral du Canada 2009-01-15 -  
Nouveau Parti démocratique 2005-03-24 - 2006-10-30
Indépendant (Nouveau Parti démocratique) 2006-10-31 - 2009-01-14
Comités - Sénat

On trouve ci-après la composition des comités par session. Tous les parlementaires ayant siégé à un comité à tout moment durant une session figurent sur la liste.

Comité Rôle Mandat
Comité permanent des affaires juridiques et constitutionnelles Membre 42e législature, 1re session
(2015-12-03 -  )
Comité permanent des peuples autochtones Présidente 42e législature, 1re session
(2015-12-10 -  )
Comité permanent des peuples autochtones Vice-présidente 40e législature, 3e session
(2010-03-04 - 2011-03-26)
Comité permanent des peuples autochtones Vice-présidente 41e législature, 2e session
(2013-11-19 - 2015-08-02)
Comité permanent des peuples autochtones Vice-présidente 41e législature, 1re session
(2011-06-14 - 2013-09-13)
Comité permanent des peuples autochtones Membre 42e législature, 1re session
(2015-12-09 -  )
Comité permanent des peuples autochtones Membre 39e législature, 2e session
(2007-11-01 - 2008-09-07)
Comité permanent des peuples autochtones Membre 40e législature, 2e session
(2009-02-10 - 2009-12-30)
Comité permanent des affaires sociales, des sciences et de la technologie Membre 40e législature, 2e session
(2009-02-10 - 2009-12-30)
Sous-comité sur les villes du Comité sénatorial permanent des affaires sociales, des sciences et de la technologie Membre 40e législature, 2e session
(2009-02-25 - 2009-12-30)
Comité permanent de l’énergie, de l’environnement et des ressources naturelles Membre 40e législature, 3e session
(2010-04-12 - 2010-04-14)
Comité permanent des affaires sociales, des sciences et de la technologie Membre 40e législature, 3e session
(2010-03-04 - 2011-03-26)
Comité permanent des droits de la personne Membre 40e législature, 3e session
(2010-05-13 - 2010-08-25)
Comité permanent de l’énergie, de l’environnement et des ressources naturelles Membre 41e législature, 1re session
(2012-06-05 - 2012-06-05)
Comité permanent des affaires sociales, des sciences et de la technologie Membre 41e législature, 1re session
(2013-03-18 - 2013-05-01)
Comité permanent des droits de la personne Membre 41e législature, 1re session
(2011-11-21 - 2011-11-22)
Comité permanent des peuples autochtones Membre 41e législature, 2e session
(2013-10-24 - 2015-08-02)
Comité permanent des affaires sociales, des sciences et de la technologie Membre 41e législature, 2e session
(2013-10-24 - 2014-03-26)
Comité permanent des peuples autochtones Membre 39e législature, 1re session
(2006-04-06 - 2007-09-14)
Comité permanent des affaires sociales, des sciences et de la technologie Membre 42e législature, 1re session
(2015-12-09 -  )
Comité permanent des pêches et des océans Membre 42e législature, 1re session
(2015-12-03 -  )
Comité permanent des peuples autochtones Membre 41e législature, 1re session
(2011-06-09 - 2013-09-13)

Publications choisies

Le document suivant est une bibliographie sélective contenant les principaux titres ou contributions de la collection d’ouvrages publiés par des parlementaires. Pour en apprendre davantage au sujet des œuvres écrites par des parlementaires, consultez une bibliothèque près de chez vous.

Aucun effort n’a été ménagé pour garantir l’exactitude de l’information qui suit. Si vous trouvez des erreurs, écrivez-nous à parlinfo@parl.gc.ca.

Potentiation of the biochemical effects of beta-phenylethylhydrazine by deuterium substitution. Biochemical Pharmacology. 32 (9):1519-22 May 1, 1983

Release of monoamines from striatal slices by phenelzine and beta-phenylethylamine. Progress in Neuro-psychopharmacology & Biological Psychiatry. 7 (4):797-800 1983

Inhibition of polyphosphoinositide turnover in rat cerebral cortex by clonidine. Life Sciences. 45 (11):993-9 1989

Polymorphism of a class 3 aldehyde dehydrogenase present in human saliva and in hair roots. Alcoholism, Clinical and Experimental Research. 19 (2):420-6 Apr. 1995

Effect of deuterium substitution on the disposition of intraperitoneal tryptamine. Biochemical Pharmacology. 35 (17):2893-6 Sept. 1, 1986

Cutaneous vasomotor sensitivity to ethanol and acetaldehyde: subtypes of alcohol-flushing response among Chinese. Alcoholism, Clinical and Experimental Research. 14 (6):932-6 Dec. 1990

Methylphenidate-like stimulants in vitro release [3H]tyramines but not [14C]dopamine. European Journal of Pharmacology. 69 (3):371-4 Jan. 29, 1981

Uptake of para-tyramine and meta-tyramine into slices of the caudate nucleus and hypothalamus of the rat. Neurochemical Research. 4 (5):633-42 Oct. 1979

Effect of chronic deuterated and non-deuterated phenelzine on rat brain monoamines and monoamine oxidase. Naunyn-Schmiedeberg's Archives of Pharmacology. 337 (3):279-83 Mar. 1988

Tryptamine transport in rat brain slices: a comparison with 5-hydroxytryptamine. Neurochemical Research. 9 (95):617-28 May 1984

Effects of beta-phenylethylamine on polyphosphoinositide turnover in rat cerebral cortex. Neurochemical Research. 14 (1):63-7 Jan. 1989

The biosynthesis of p-tyramine, m-tyramine, and beta-phenylethylamine by rat striatal slices. Journal of Neuroscience Research. 10 (2):211-20 1983

Effect of monofluoromethyldopa (MFMD) on trace amine levels. Life Sciences. 40 (6):571-5 Feb. 9, 1987

Isoenzymes of aldehyde dehydrogenase in human lymphocytes. Alcoholism, Clinical and Experimental Research. 14 (4):534-8 Aug. 1990

The role of catecholamines, 5-hydroxytryptamine and m-tyramine in the behavioural effects of m-tyrosine in the rat. European Journal of Pharmacology. 84 (3):139-49 Oct. 22, 1982

Conjugation of phenylacetic acid and m- and p-hydroxyphenylacetic acids in the rat striatum. Life Sciences. 53 (11):901-9 1993

Inibition of rat liver microsomal CYP1A2 and CYP2B1 activity by N-(2-heptyl)-N-methyl-propargylamine and by N-(2-heptyl)-propargylamine. Drug Metabolism and Disposition. 29 (8):1156-61 Aug. 2001

Effects of monoamine oxidase inhibitors on the acid metabolites of some trace amines and of dopamine in the rat striatum. Biochemical Pharmacology. 45:1317-22 Mar. 24, 1993

Biphasic behavioural stimulation induced by a monoamine oxidase-inhibiting antidepressant. Progress in Neuro-psychopharmacology & Biological Psychiatry. 6 (4):383-8 1982

Inhibition of aromatic L-amino acid decarboxylase and tyrosine aminotransferase by the monoamine oxidase inhibitor phenelzine. Journal of Neurochemistry. 46 (6):1899-903 June 1986

Release of some endogenous trace amines from rat striatal slices in the presence and absence of a monoamine oxidase inhibitor. Life Sciences. 44 (17):1149-56 1989

The in vitro release of endogenous m-tyramine, p-tyramine and dopamine from rat striatum. Neurochemical Research. 7 (6):705-16 June 1982

Absence of the atypical mitochondrial aldehyde dehydrogenase (ALDH2) isozyme in Saskatchewan Cree Indians. Human Heredity. 43 (2):116-20 Mar./Apr. 1993

Behavioural and neurochemical effects of meta-tyrosine in the rat. Progress in Neuro-psychopharmacology & Biological Psychiatry. 6 (4):389-94 1982

Involvement of brain trace amines in the behavioural effects of phenelzine. Neurochemical Research. 13 (2):113-9 Feb. 1988

Acceleration of the biosynthesis of rat striatal dopamine by incubation and by administration of gamma-butyrolactone. Journal of Neuroscience Research. 8 (1):57-65 1982

Atypical antipsychotics attenuate neurotoxicity of beta-amyloid(25-35) by modulating Bax and Bcl-X(l/s) _expression and localization. Journal of Neuroscience Research. 74 (6):942-7 Dec .15, 2003

Metabolism and pharmacokinetics, in the rat, of (R)-N-(2-Heptyl)Methyl-propargylamine (R-2HMP), a new potent monoamine oxidase inhibitor and antiapoptotic agent. Drug Metabolism and Disposition. 28 (2):147-54 Feb. 2000

Uptake and release of meta-tyramine, para-tyramine, and dopamine in rat striatal slices. Neurochemical Research. 3 (6):775-91 Dec. 1978

Dare to be brave: stand up for yourself. In : Women in the Canadian academic tundra: challenging the chill / [edited by] Elena Hannah, Linda Paul, Swani Vethamany-Globus. Montreal: McGill-Queen's University Press; p. 47-50. c2002

A comparison of the effects of methylphenidate and amphetamine on the simultaneous release of radiolabelled dopamine and p- or m-tyramine from rat striatal slices. European Journal of Pharmacology. 68 (1):33-40 Nov. 7, 1980

Olanzapine and quetiapine protect PC12 cells from beta-amyloid peptide(25-35)-induced oxidative stress and the ensuing apoptosis. Journal of Neuroscience Research. 81 (4):572-80. Aug. 15, 2005

Alterations in trace amine and trace acid concentrations in isolated aggressive mice. Pharmacology, Biochemistry, and Behavior. 17 (6):1291-4 Dec. 1982

Formation of beta-phenylethylamine from the antidepressant, beta-phenylethylhydrazine. Biochemical Pharmacology. 34 (1):1925-9 June 1, 1985

Effects of deuterium substitution on the catabolism of beta-phenylethylamine: an in vivo study. Journal of Neurochemistry. 46 (2):399-404 Feb. 1986

The University of Saskatchewan: a portrait. Women's Education. 9 (2):23 1991

Antipsychotic drugs cause glial cell line-derived neurotrophic factor secretion from C6 glioma cells. Journal of Psychiatry and Neuroscience. 31 (1):32-7 Jan. 2006

Biosynthesis and excretion of meta and para tyramine in the rat. Life Sciences. 14 (12):2497-506 June 16, 1974

Potentiation of the behavioural effects of the antidepressant phenelzine by deuterium substitution. Psychopharmacology. 81 (2):122-5 1983

Reversible amine -- selective effects of acute and chronic brofaromine treatment in the rat. Life Sciences. 51 (1):59-66 1992

Microassay for the estimation of monoamine oxidase activity. Analytical Biochemistry. 72:637-42 May 7, 1976

The behavioural effects of phenelzine and phenylethylamine may be due to amine release. Brain Research Bulletin. 12 (1):23-8 Jan. 1984

Demonstration of an anti-oxidative stress mechanism of quetiapine. FEBS Journal. 275 (14):3718-28 Jul. 2008

An in vitro study of the uptake and release of m- and p-tyramine. Thesis (Ph.D.) -- University of Saskatchewan; xiii, 157 leaves. 1981

Effect of decarboxylase inhibitors on brain p-tyrosine levels. Biochemical Pharmacology. 36 (8):1373-6 Apr. 15, 1987

Changes in brain catecholamine levels following DL-dopa are not potentiated by deuterium substitution. Progress in Neuro-psychopharmacology & Biological Psychiatry. 9 (5):675-80 1985

Hydroxylation of beta-phenylethylamine in the rat. Life Sciences. 15 (9):1673-83 Nov. 1, 1974

Release of radiolabeled dopamine, p-tyramine, and m-tyramine from rat striatal slices by some aminotetralins. Neurochemical Research. 6 (4):365-75 Apr. 1981

Effects of antidepressant drugs on inositol phospholipid hydrolysis in rat cerebral cortical slices. Neurochemical Research. 14 (11):1047-52 Nov. 1989

The effect of some drugs on the urinary excretion of some aryl alkyl amines in the rat. Research Communications in Chemical Pathology and Pharmacology. 11 (1):73-7 May 1975

Identification and metabolism of certain biogenic amines in brain: a thesis submitted to the Faculty of Graduate Studies in partial fulfilment of the requirements for the degree of Master of Science in the Department of Biochemistry. Saskatoon, Sask.: s.n.; x, 95 leaves. 1970

Effect of deuterium substitution on the penetration of beta-phenylethylhydrazine into the rat brain. Biochemical Pharmacology. 37 (13):2703-4 July 1, 1988

Aliphatic N-methylpropargylamines: monoamine oxidase-B inhibitors and antiapoptotic drugs. Advances in Pharmacology. 42:308-11 1998